Home/Filings/4/0001179110-22-001143
4//SEC Filing

BRUM LYNNE H 4

Accession 0001179110-22-001143

CIK 0001121702other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 2:33 PM ET

Size

8.0 KB

Accession

0001179110-22-001143

Insider Transaction Report

Form 4
Period: 2022-02-10
BRUM LYNNE H
VP Marketing and Corp Comm
Transactions
  • Award

    Common Stock

    2022-02-10$3.83/sh+5,891$22,56310,582 total
  • Award

    Stock Option (right to buy)

    2022-02-10+18,00018,000 total
    Exercise: $3.83Exp: 2032-02-10Common Stock (18,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    4,880
Footnotes (3)
  • [F1]The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023.
  • [F2]Shares acquired as Issuer matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.
  • [F3]These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026.

Issuer

YIELD10 BIOSCIENCE, INC.

CIK 0001121702

Entity typeother

Related Parties

1
  • filerCIK 0001197017

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 2:33 PM ET
Size
8.0 KB